Oxolinic acid

Oxolinic acid is a quinolone antibiotic developed in Japan in the 1970s.[1][2] Dosages 12–20 mg/kg orally administered for five to ten days. The antibiotic works by inhibiting the enzyme DNA gyrase. It also acts as a dopamine reuptake inhibitor and has stimulant effects in mice.[3]

Oxolinic acid

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01MB05 (WHO)
Identifiers
IUPAC name 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline- 7-carboxylic acid
CAS Number	14698-29-4^Y
PubChem CID	4628
ChemSpider	4467^N
UNII	L0A22B22FT
KEGG	D02301^N
ChEBI	CHEBI:138856^N
ChEMBL	ChEMBL416755^N
CompTox Dashboard (EPA)	DTXSID1021089
ECHA InfoCard	100.035.213
Chemical and physical data
Formula	C13H11NO5
Molar mass	261.233 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O
InChI InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)^N Key:KYGZCKSPAKDVKC-UHFFFAOYSA-N^N
^NY (what is this?)  (verify)

See also

• Amfonelic acid
• Fluoroquinolone

References

1. JP Patent 49138244
2. Gleckman R, Alvarez S, Joubert DW, Matthews SJ (August 1979). "Drug therapy reviews: oxolinic acid". American Journal of Hospital Pharmacy. 36 (8): 1077–9. PMID 384788.
3. Garcia de Mateos-Verchere J, Vaugeois JM, Naudin B, Costentin J (December 1998). "Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor". European Neuropsychopharmacology. 8 (4): 255–9. doi:10.1016/S0924-977X(97)00083-7. PMID 9928913.